Skip to main content

Advertisement

Log in

Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases

  • Original Articles
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

We investigated serum levels of interleukin-6 (IL-6), interferon-gamma (IFN-γ), and tumor necrosis factor alpha (TNFα) from patients with systemic lupus erythematosus (SLE) and its various clinical manifestations of disease and from patients with rheumatoid arthritis (RA) and other rheumatic diseases. The serum levels of IL-6 and IFN-γ were highly elevated from patients with SLE associated with lymphadenopathy (LN) or nephrotic syndrome (NS). On the contrary, the serum levels of TNFα were elevated from most patients with SLE associated with thrombocytopenia (TP). However, serum levels of TNFα were in the normal range from patients with SLE associated with NS, LN, or central nervous system disease. Of interest, patients with SLE associated with humoral immunodeficiency disorder, hypogammaglobulinemia, had highly elevated levels of serum IL-6. The concanavalin A-stimulated mononuclear cells (MNC) of patients with SLE associated with TP secreted highly elevated levels of TNFα compared to other patient groups. We suggest that abnormal production of various cytokines in SLE is an intrinsic defect of MNC and the immune system that may be the key element for a variety of clinical manifestations of this disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Similar content being viewed by others

References

  1. Dinarello CA, Mier JW: Current concepts, lymphokines. N Engl J Med 317:940–945, 1987

    Google Scholar 

  2. Beutler B, Cerami A: The biology of cachectin/TNF—a primary mediator of the host response. Annu Rev Immunol 7:625–655, 1989

    Google Scholar 

  3. Kishimoto T: The biology of interleukin-6. Blood 74:1–10, 1989

    Google Scholar 

  4. Sneller MC, Strober W: Abnormalities of lymphokine gene expression in patients with common variable immunodeficiency. J Immunol 144:3762–3769, 1990

    Google Scholar 

  5. Schattner A, Lachini M, Livnen A, Pras M, Hahn T: Tumor necrosis factor in familial mediterranean fever. Am J Med 90:434–438, 1991

    Google Scholar 

  6. Linker-Israeli M, Deans RJ, Wallace DJ, Prehn J, Ozeri-Chen T, Klinberg JR: Elevated levels of endogenous IL-6 in systemic lupus erythematosus: A putative role in pathogenesis. J Immunol 147:117–123, 1991

    Google Scholar 

  7. Helfgott DC, Tatter SB, Santhanam U, Clarick RM, Bhardwaj N, May T, Sehgal PB: Multiple forms of IFN-B2/IL-6 in serum and body fluids during acute bacterial infection. J Immunol 142:948–953, 1989

    Google Scholar 

  8. Clark IA, Cowden WB, Butcher GA, Hunt NH: Possible role of tumor necrosis factor in the pathology of malaria. Am J Pathol 129:192–199, 1987

    Google Scholar 

  9. Barral-Netto M, Badaro R, Almeida R, Santos S, Badaro F, Falcoff R: Tumor necrosis factor (cachectin) in human visceral leishmaniasis. J Infect Dis 163:853–857, 1991

    Google Scholar 

  10. Akocer-Varela J, Aleman-Hoey D, Alarcon-Segovia D: Interleukin-1 and interleukin-6 are increased in the cerebrospinal fluid of patients with CNS lupus erythematosus and correlate with local late T cell activation markers. Lupus 1:111–117, 1992

    Google Scholar 

  11. Bhardwaj N, Santhanam U, Lau L, Tatter S, Ghrayed J, Rivelis M, Steinman R, Sehgal P, May L: IL-6/IFN-B2 in synovial effusion of patients with rheumatoid arthritis and other arthritides. Identification of several isoforms and studies of cellular sources. J Immunol 143:2153–2159, 1989

    Google Scholar 

  12. Schur PH, Sandson J: Immunologic factors and clinical activity in systemic lupus erythematosus. N Engl J Med 9:533–538, 1968

    Google Scholar 

  13. Smith HR, Steinberg AD: Autoimmunity—a perspective. Ann Rev Immunol 1:175–189, 1983

    Google Scholar 

  14. Tsokos GC, Margrath IT, Balow JE: Epstein-Barr virus induces normal B cell responses but defective suppressor T cell response in patients with systemic lupus erythematosus. J Immunol 131:1797–1801, 1983

    Google Scholar 

  15. Raziuddin S, Nur MA, Al-Wabel AA: Selective loss of the CD4+ inducers of suppressor T cell subsets (2H4+) in active systemic lupus erythematosus. J Rheumatol 16:1315–1319, 1989

    Google Scholar 

  16. Raziuddin S, Danial HB, Kelley M: OKT4 T cell abnormality in patients with systemic lupus erythematosus: HLA-DR antigen expressions. Clin Immunol Immunopathol 48:42–49, 1988

    Google Scholar 

  17. Fauci AS, Steinberg AD, Haynes BF, Whalen G: Immunoregulatory aberration in systemic lupus erythematosus. J Immunol 121:1473–1479, 1978

    Google Scholar 

  18. Campen DH, Horwitz DA, Quismorio FP, Ehresmann GR, Martin WJ: Serum levels of interleukin-2 receptor and activity of rheumatic diseases characterized by immune system activation. Arth Rheum 31:1358–1364, 1988

    Google Scholar 

  19. Wilson JG, Fearon DT: Altered expression of complement receptors as a pathogenetic factor in systemic lupus erythematosus. Arth Rheum 27:1321–1327, 1984

    Google Scholar 

  20. Morimoto C, Reinherz EL, Distaso JA, Steinberg AD, Schlossman SF: Relationship between systemic lupus erythematosus T cell subsets, anti-T cell antibodies and T cell functions. J Clin Invest 73:689–700, 1984

    Google Scholar 

  21. Raziuddin S, Al-Janadi MA, Al-Wabel AA: Soluble interleukin-2 receptor levels in serum and its relationship to T cell abnormality and clinical manifestations of the disease in patients with systemic lupus erythematosus. J Rheumatol 18:831–836, 1991

    Google Scholar 

  22. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arth Rheum 25:271–1277, 1982

    Google Scholar 

  23. Arnett FC, Edworthy S, Block DA,et al.: The 1987 revised ARA criteria for rheumatoid arthritis. Arth Rheum 30:317, 1987

    Google Scholar 

  24. Talal N, Moutsopoulos HM, Kasan S: Sjogren's Syndrome. Heidelberg, Springer-Verlag, 1987

    Google Scholar 

  25. Bird HA, Esselinck W, Dixon AS, Mowat AG, Wood PHN: An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis 38:434–439, 1979

    Google Scholar 

  26. Raziuddin S, Al-Janadi MA, Al-Wabel AA: T cell receptor alpha/beta chain-CD3 protein complex defect in systemic lupus erythematosus. T cell function. Am J Med 1992 (in press)

  27. Scuderi P, Sterling K, Lam K, Finley P, Ryan K, Ray C, Peterson E, Slymen D, Salmon S: Raised serum levels of tumour necrosis factor in parasitic infections. Lancet 2:1364–1365, 1986

    Google Scholar 

  28. Tsokos GC, Smith PL, Balow JE: Development of hypogammaglobulinemia in a patient with systemic lupus erythematosus. Am J Med 81:1081–1084, 1986

    Google Scholar 

  29. Raziuddin S, Danial HB: OKT4+ T cell deficiency and an association of immunoglobulin deficiency in systemic lupus erythematosus. Clin Exp Immunol 72:466–469, 1988

    Google Scholar 

  30. Raziuddin S, Nur MA, Al-Janadi MA: CD4+ T lymphocyte deficiency and function in systemic lupus erythematosus and rheumatoid arthritis. Arth Rheum 33:1864–1865, 1990

    Google Scholar 

  31. Warrington RJ: B cell differentiation factor production in systemic lupus erythematosus. J Rheumatol 15:55–58, 1988

    Google Scholar 

  32. Abdou NI, Sagawa A, Rascual E, Habert J, Sadeghee S: Suppressor T cell abnormality in idiopathic systemic lupus erythematosus. Clin Immunol Immunopathol 6:192–199, 1976

    Google Scholar 

  33. Wolf RE, Brelsford WG: Soluble interleukin-2 receptors in systemic lupus erythematosus. Arth Rheum 31:729–735, 1988

    Google Scholar 

  34. Linker-Israeli M, Bakke AC, Kitridou RC, Gendler S, Gillis S, Horwitz DA: Defective production of interleukin-1 and interleukin-2 in patients with systemic lupus erythematosus. J Immunol 130:2651–2655, 1983

    Google Scholar 

  35. Houssiau FA, Devogelaer J-P, Van Damme J, Deuxchaisnes C, Van Snick J: Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arth Rheum 31:784–788, 1988

    Google Scholar 

  36. Firestein GS, Alvaro-Garcia JM, Maki R: Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J Immunol 144:3347–3353, 1990

    Google Scholar 

  37. Dasgupta B, Panayi GS: Interleukin-6 in serum of patients with polymalgia rheumatica and giant cell arteritis. Br J Rheumatol 29:456–458, 1990

    Google Scholar 

  38. Linker-Israeli M: Cytokine abnormalities in human lupus. Clin Immunol Immunopathol 63:10–12, 1992

    Google Scholar 

  39. Alcocer-Varela J, Aleman-Hoey D, Alarcon-Segovia D: Interleukin-1, interleukin-6 activities are increased in the cerebrospinal fluid of patients with CNS lupus erythematosus and correlates with local late T-cell activation markers. Lupus 1:111–117, 1992

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Al-Janadi, M., Al-Balla, S., Al-Dalaan, A. et al. Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases. J Clin Immunol 13, 58–67 (1993). https://doi.org/10.1007/BF00920636

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00920636

Key words

Navigation